Results 21 to 30 of about 99,140 (146)

MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1

open access: yesHaematologica, 2012
Background Mobilization of hematopoietic stem/progenitor cells from the bone marrow to the peripheral blood by granulocyte colony-stimulating factor is the primary means to acquire stem cell grafts for hematopoietic cell transplantation.
Ombretta Salvucci   +8 more
doaj   +1 more source

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

open access: yesHaematologica, 2013
In Europe, the combination of plerixafor + granulocyte colony-stimulating factor is approved for the mobilization of hematopoietic stem cells for autologous transplantation in patients with lymphoma and myeloma whose cells mobilize poorly. The purpose of
Nigel Russell   +11 more
doaj   +1 more source

Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer

open access: yesCase Reports in Oncology, 2019
Granulocyte colony-stimulating factor (G-CSF)-producing bladder cancer is rare, with only 75 cases reported in Japan. A 67-year-old woman was referred to our institution for the further examination of gross hematuria.
Ryota Morinaga   +4 more
doaj   +1 more source

Granulocyte-colony stimulating factor producing rectal cancer

open access: yesWorld Journal of Surgical Oncology, 2008
Background Granulocyte-colony stimulating factor (G-CSF)-producing cancer has been reported to occur in various organs, especially the lung. However, G-CSF-producing colorectal cancer (CRC) has never been reported in the English literature.
Satoh Mikinori   +10 more
doaj   +1 more source

Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors

open access: yesHaematologica, 2011
Background The number of CD34+ cells mobilized from bone marrow to peripheral blood after administration of granulocyte colony-stimulating factor varies greatly among healthy donors.
Beatriz Martín-Antonio   +8 more
doaj   +1 more source

Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor

open access: yesCase Reports in Gastroenterology, 2020
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein which stimulates the proliferation, differentiation, and functional activation of myeloid hematopoietic cells. G-CSF-producing pancreatic cancer is rare and its prognosis is strikingly poor.
Yoshifumi Morita   +10 more
doaj   +1 more source

Granulocyte colony‐stimulating factor is not pathogenic in lupus nephritis

open access: yesImmunity, Inflammation and Disease, 2021
Systemic lupus erythematosus (lupus) is an autoimmune disease characterized by autoantibodies that form immune complexes with self‐antigens, which deposit in various tissues, leading to inflammation and disease.
Timothy A. Gottschalk   +3 more
doaj   +1 more source

Double‐ring sign in granulocyte colony‐stimulating factor‐induced vasculitis

open access: yesRespirology Case Reports, 2022
Key message If a double‐ring sign is found in contrast‐enhanced computed tomography, this should raise concern not only for Takayasu arteritis, but also for granulocyte colony‐stimulating factor‐induced vasculitis.
Reimi Mizushima   +5 more
doaj   +1 more source

Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2016
The use of high-dose chemotherapy with autologous support of hematopoietic progenitor cells is an effective strategy to treat various hematologic neoplasms, such as non-Hodgkin lymphomas and multiple myeloma.
Marco Aurélio Salvino, Jefferson Ruiz
doaj   +1 more source

A nitrous oxide/oxygen fixed mixture to reduce pain induced by the hypodermic injection: study protocol for a randomized, controlled trial

open access: yesTrials
Background Patients with hematological malignancies received multiple hypodermic injections of recombinant human granulocyte colony-stimulating factor.
Jun-Jun Zhang   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy